PETRARCA, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 2.530
EU - Europa 1.314
AS - Asia 840
SA - Sud America 66
AF - Africa 28
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.796
Nazione #
US - Stati Uniti d'America 2.514
RU - Federazione Russa 547
SG - Singapore 248
CN - Cina 200
HK - Hong Kong 149
SE - Svezia 148
PL - Polonia 143
IE - Irlanda 124
VN - Vietnam 91
IT - Italia 71
DE - Germania 68
KR - Corea 60
BR - Brasile 52
FI - Finlandia 49
UA - Ucraina 39
FR - Francia 38
GB - Regno Unito 37
IN - India 23
JP - Giappone 20
TR - Turchia 18
AU - Australia 16
CI - Costa d'Avorio 12
BE - Belgio 11
NL - Olanda 10
CA - Canada 8
JO - Giordania 8
MX - Messico 7
AR - Argentina 6
BD - Bangladesh 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
ES - Italia 4
MA - Marocco 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
IQ - Iraq 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
CH - Svizzera 2
DK - Danimarca 2
EG - Egitto 2
EU - Europa 2
GR - Grecia 2
LT - Lituania 2
MT - Malta 2
NP - Nepal 2
PK - Pakistan 2
AM - Armenia 1
BY - Bielorussia 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
ID - Indonesia 1
KE - Kenya 1
MM - Myanmar 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.796
Città #
Santa Clara 526
Ashburn 279
Fairfield 193
Singapore 180
Chandler 164
Warsaw 142
San Jose 135
Dublin 124
Hong Kong 120
Wilmington 88
Seattle 87
Beijing 85
Cambridge 85
Ann Arbor 83
Woodbridge 79
Jacksonville 64
Seoul 60
Houston 58
The Dalles 46
Buffalo 44
Boardman 31
Princeton 30
Lauterbourg 27
Los Angeles 25
Boston 24
Ho Chi Minh City 24
Bremen 23
Hanoi 23
Altamura 22
Lawrence 20
Tokyo 20
Melbourne 16
San Diego 16
Shanghai 14
Dallas 13
Mumbai 13
Turku 13
Abidjan 12
Izmir 12
Brussels 11
Falls Church 11
Medford 11
Munich 11
New York 11
Moscow 8
Frankfurt am Main 7
London 7
Andover 6
Brooklyn 6
Hefei 6
Helsinki 6
Da Nang 5
Norwalk 5
Paris 5
São Paulo 5
Atlanta 4
Brno 4
Chicago 4
Cluj-Napoca 4
Old Bridge 4
Orem 4
Washington 4
Abuja 3
Amsterdam 3
Bratislava 3
Curitiba 3
Ferriere 3
Guangzhou 3
Kent 3
Milan 3
Montalbano Jonico 3
Montreal 3
Phoenix 3
Poplar 3
Stockholm 3
Ankara 2
Athens 2
Bern 2
Biên Hòa 2
Brasília 2
Denver 2
Dong Ket 2
Duque de Caxias 2
Falkenstein 2
Florence 2
Helena 2
Hillsboro 2
Hải Dương 2
Istanbul 2
Mexico City 2
Natal 2
Nilópolis 2
Ninh Bình 2
Padova 2
Quito 2
Quảng Ngãi 2
San Francisco 2
Thái Bình 2
Toronto 2
Valletta 2
Totale 3.258
Nome #
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment. 302
Acute viral hepatitis increases liver stiffness values measured by transient elastography 231
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection 219
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 207
Host genetic determinants in HCV-related mixed cryoglobulinemia 198
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 197
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 196
Host genetic determinants in HCV-related mixed cryoglobulinemia 190
Analysis of HCV persistence in patients with sustained virological response 184
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 174
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 170
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 170
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 168
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 167
Host genetic determinants in HCV-related mixed cryoglobulinemia 161
Transient elastography (TE) is more effective for the identification of HCV patients with severe (> F3) rather than significant (> F2) liver fibrosis 154
Transient elastography (TE) is more effective for the identification of HCV patients with advanced (F3-F4) rather than significant (F2-F4) liver fibrosis 151
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 148
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 138
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 135
Effects of depletion of B cell by anti-CD20 monoclonal antibody in HCV+ mixed cryoglobulinemia (MC) and liver cirrhosis 134
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 133
Can depletion of B-cells by anti-CD20 monoclonal antibody in HCV plus mixed cryoglobulinemia (MC) improve liver cirrhosis? 123
Efficacy of rituximab in severe and mild abdominal vasculitis in the course of mixed cryoglobulinemia 119
Mixed cryoglobulinemia syndrome is a negative prognostic factor in the standard of care (Peg-IFN+ribavirin) anti-HCV therapy 119
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 115
Effect of rituximab on advanced liver disease in patients with HCV-related mixed cryoglobulinemia. 112
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 111
L'epatite B: un problema antico di rinnovata attualità 87
Utilizzo del Rituximab (Anticorpo Monoclonale anti-CD20) nel Trattamento dei Pazienti con Sindrome Crioglobulinemica HCV-correlata e Malattia Epatica Avanzata 86
Totale 4.799
Categoria #
all - tutte 13.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.072


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 0 17
2021/2022237 7 31 4 10 13 9 11 15 11 5 51 70
2022/2023621 53 69 35 68 64 115 75 41 82 4 13 2
2023/2024192 14 23 32 15 9 31 5 53 2 2 2 4
2024/20251.451 64 150 94 226 455 182 15 90 60 19 58 38
2025/20261.181 168 175 62 62 144 64 174 51 138 111 20 12
Totale 4.799